Regional differences in the response of human pre-adipocytes to PPARγ and RXRα agonists

Diabetes

Volumn 51, Issue 3, 2002, Pages 718-723

  Sewter, Ciaran P ^a   Blows, Fiona ^a   Vidal Puig, Antonio ^a   O'Rahilly, Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 6 [1 (5,6,7,8 TETRAHYDRO 3,5,5,8,8 PENTAMETHYL 2 NAPHTHYL)CYCLOPROPYL]NICOTINIC ACID; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; ISOPROTEIN; LIGAND; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA1; RETINOID X RECEPTOR; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR ALPHA AGONIST; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; MALE; OMENTUM; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

EID: 0036309971     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.3.718     Document Type: Article

References (35)

1. The degree of masculine differentiation of obesities, a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease
2. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography
3. The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18-79 years
4. Regional obesity and risk of cardiovascular disease: The Framingham Study
5. Relation of body fat distribution to metabolic complications of obesity
6. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution
7. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden
8. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913
9. Regional differences in the control of lipolysis in human adipose tissue
10. Metabolism of mammary, abdominal, and femoral adipocytes in women before and after menopause
11. Metabolism of adipose tissue in intraabdominal depots of nonobese men and women
12. Metabolism of adipose tissue in intraabdominal depots in severely obese men and women
13. Regional differences in triglyceride breakdown in human adipose tissue: Effects of catecholamines, insulin, and prostaglandin E2
14. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis
15. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
16. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
17. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
18. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones
19. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptorgamma: Binding and activation correlate with antidiabetic actions in db/db mice
20. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes
21. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation
22. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
23. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents
24. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes
25. PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate
26. Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes
27. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha
28. Autoinduction of nuclear hormone receptors during metamorphosis and its significance
29. Autoinduction of nuclear receptor genes and its significance
30. Differential regulation of peroxisome proliferator activated receptor γ1 (PPARγ1) and PPARγ 2 messenger RNA expression in the early stages of adipogenesis
31. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene
32. The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction
33. Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators
34. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARγ) heterodimers: Intermolecular synergy requires only the PPARγ hormone-dependent activation function
35. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor